Results 151 to 160 of about 1,568,281 (351)

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite the availability of effective therapies for Multiple Sclerosis (MS), the unpredictable nature of disease progression and the variability in individual treatment outcomes call for reliable biomarkers. This pilot study aims to investigate the potential of plasma circulating microRNAs (miRNAs) as predictive biomarkers for ...
Fortunata Carbone, Alessandra Colamatteo, Teresa Micillo, Gianmarco Abbadessa, Silvia Garavelli, Clorinda Fusco, Claudia Russo, Francesco Perna, Federica Garziano, Claudia La Rocca, Maria Mottola, Giorgia Teresa Maniscalco, Simona Bonavita, Antonio Luca Spiezia, Alessia Castiello, Roberta Lanzillo, Vincenzo Brescia Morra, Claudio Procaccini, Paola de Candia, Giuseppe Matarese   +19 more
wiley   +1 more source

Viral Diseases [PDF]

, 2018
Sherif R. Zaki, M. Kelly Keating
openaire   +2 more sources

Development and validation of the Post-Pandemic Fear of Viral Disease scale and its relationship with general anxiety disorder: a cross-sectional survey from Pakistan. [PDF]

BMC Public Health, 2023
Mahmood QK, Jalil A, Farooq M, Akbar MS, Fischer F.   +4 more
europepmc   +2 more sources

Detection of pathogenic viruses in the urban wastewater in Kuwait-implications for monitoring viral disease outbreaks. [PDF]

Environ Monit Assess, 2023
Jamil K, Abdulrazack N, Fakhraldeen S, Kumar V, Al-Subiai S, Al-Aati T, Kamal H, Husain F, Ahmed I, Hussein I.   +9 more
europepmc   +1 more source

Relevance of Kappa and Lambda Free Light Chains in Autoimmune Astrocytopathy Associated With Anti‐GFAP Antibodies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction The kappa‐free light chain (κ‐FLC) index is known to be highly sensitive and specific for diagnosing multiple sclerosis (MS), while little is understood about lambda (λ)‐FLC. This study assessed the κ‐FLC and λ‐FLC indices in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy.
Michael Levraut, Romain Marignier, Mikael Cohen, Jeanne Benoit, Cassandre Landes‐Chateau, Elisabeth Maillart, Marion Cremoni, Barbara Seitz‐Polski, Anne‐Laurie Pinto, Pauline Dumez, Jérôme Honnorat, Christine Lebrun‐Frenay   +11 more
wiley   +1 more source

β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease

Alzheimer’s Research & Therapy
Background β-synuclein (β-syn), mainly expressed in central nerve system, is one of the biomarkers in cerebrospinal fluid (CSF) and blood for synaptic damage, which has been reported to be elevated in CSF and blood of the patients of prion diseases (PrDs)
Bing Xu, Kang Xiao, Xiaoxi Jia, Rundong Cao, Donglin Liang, Ruhan A, Weiwei Zhang, Chunjie Li, Liping Gao, Cao Chen, Qi Shi, Xiaoping Dong   +11 more
doaj   +1 more source

Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease. [PDF]

Front Med (Lausanne), 2022
Herzog S, Fragkou PC, Arneth BM, Mkhlof S, Skevaki C.   +4 more
europepmc   +1 more source

USE OF TISSUE CULTURES IN ETIOLOGIC STUDIES ON VIRAL DISEASES

, 1955
Thomas H. Weller
openalex   +1 more source

Paroxysmal Dyskinesias Secondary to HHV‐6A Encephalitis: The First Case Report and Literature Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Paroxysmal dyskinesias encompasses a spectrum of conditions marked by intermittent involuntary movements, with paroxysmal kinesigenic dyskinesias being the most common phenotype. Central nervous system infection is a rare cause of paroxysmal dyskinesias.
Zhuoran Wang, Haiting Li, Xiaoping Du, Qiong Wang, Yating Zhang, Huifang Wang   +5 more
wiley   +1 more source

Genomic characteristics of 12 HBV-I strains in the 2020 national HBV serosurvey in China

Biosafety and Health
Hepatitis B virus (HBV) is categorized into ten distinct genotypes (A − J), with over 40 subgenotypes identified to date. HBV genotype I (HBV-I), an inter-genotypic recombinant, has emerged during the evolution history of HBV. In this study, we conducted
Qiudong Su, Liping Shen, Xiaoqi Guo, Shuang Zhang, Feng Qiu, Shengli Bi, Feng Wang   +6 more
doaj